Morgan Stanley »

Cadrenal Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Cadrenal Therapeutics (CVKD) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Cadrenal Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cadrenal Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cadrenal Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2026-03-31 $512 100 5.12
2025-06-30 $5.2k 430 12.05
2024-12-31 $17k 1.1k 14.49